Second Sight Medical (EYES) Tops Q1 EPS by 3c

Second Sight Medical (NASDAQ: EYES) reported Q1 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Autoliv (ALV) Reports In-Line Q2 EPS
• Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks